Inato

Paris, France Founded: 2016 • Age: 10 yrs
AI-based patient recruitment platform

About Inato

Inato is a Healthcare company based in Paris (France) founded in 2016 by Philippe Ravaud, William Pambrun, and Jean-David Zeitoun. AI-based patient recruitment platform. Inato has raised $35.52 million across 3 funding rounds from investors including Cathay Innovation, Obvious Ventures and La Maison Partners. Inato offers products and services including AI Patient Pre-Screening and AI Site Selection. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Clinical Trials.

Company details

Inato was founded in 2016 in Paris, France, as an AI-based platform focused on patient recruitment for clinical trials. Data-driven site selection is enabled through processes that identify potential sites, collect site information, assess recruitment capabilities, and model optimization strategies. End-to-end services are provided to support personalized recruitment in the health technology sector.

  • Headquarters Paris, France
  • Founders Philippe Ravaud, William Pambrun, Jean-David Zeitoun
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website inato.com
  • Social LinkedIn X
Key Metrics
  • Total Equity Funding
    $35.52M (USD)

    in 3 rounds

  • Latest Funding Round
    $20M (USD), Series A

    Mar 2023

  • Investors

Products & Services of Inato

Inato offers a comprehensive portfolio of products and services, including AI Patient Pre-Screening and AI Site Selection.

AI Patient Pre-Screening
Patient Screening

AI tool for efficient patient eligibility checks in trials.

AI Site Selection
Site Management

Platform for identifying optimal research sites quickly.

Funding Insights of Inato

Inato has successfully raised a total of $35.52M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $20 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $35.52M
  • Total Rounds 3
  • Last Round Series A β€” $20M
  • First Round $1.52M

    (Nov 2017)

  • Investors Count 9

All 3 funding rounds of Inato with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2023$20MSeries A–Cathay Innovation
Feb 2020$14MSeries A–Obvious Ventures, Cathay Innovation
Nov 2017$1.52MSeed––
Valuation history

9 investors in total: 7 institutional and 2 angel.

Investors in Inato

Inato has secured backing from 9 investors, including venture fund and angel investors. Prominent investors backing the company include Cathay Innovation, Obvious Ventures and La Maison Partners.

All
Venture Fund
Angel
InvestorDescriptionFounded YearDomainLocation
Venture capital investments are made in technology startups through a global ecosystem.
cathayinnovation.com
Provider of venture capital investments across planetary, human, and economic health
obvious.comSan Francisco, United States
Growth-stage tech companies are invested in by La Maison Partners.
lamaisonpartners.frParis, France
topharvestcap.com
Venture capital investments are made in European tech startups from day-zero to seed.
fly.vc
Serena is engaged in venture capital investments for tech startups.
serena.vcParis, France
Seed-stage investments in startups are provided by Kima Ventures.
kimaventures.comParis, France

Bertrand Diard

French entrepreneur, angel investor, co-founder of Talend, active in tech startups
unknown_7f914995e60546fea

Franck Le Ouay

Co-founder of Criteo, active angel investor in Indian startups
unknown_effae8c82eb84ae88
Premium access

Investor details for Inato

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Inato

27 people are tracked at Inato (16 in leadership, 11 in team).

NameRoleGroup
Philippe Ravaud
Co-FounderLeadership
William Pambrun
Co-Founder & CPOLeadership
Jean-David Zeitoun
Co-Founder & CMOLeadership
Liz Beatty
Chief Strategy OfficerLeadership
Jennifer Koch
VP Of MarketingLeadership
Bastien Duret
Chief Technical OfficerLeadership
Kourosh Davarpanah
Co-founder & CEOLeadership
Kyle Ryan
Sales DirectorLeadership
Alexandre Halley
Data DirectorLeadership
Camille Thiénot
Chief of Staff & VP of FinanceLeadership
Stephanie A.
US Director, Talent AcquisitionLeadership
Quentin Bodinier
VP ProductLeadership
Carly Cooperstein
Vice President Of Trial DeliveryLeadership
Marcy Kravet
Vice President, Strategic OperationsLeadership
Alexa Hibbert
Director Of Product ManagementLeadership
Geoff Ainslie
Head Of Site PartnershipsLeadership
Maysa Jawdat
Senior Program Manager, Trial DeliveryTeam
Hugo Hahn
Senior Product Data AnalystTeam
Gavin Birchnall
Unknown RoleTeam
Charles Guillocher
Product designerTeam

7 more people are available in the full profile.

Premium access

Complete people profiles for Inato

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Inato

3 dated milestones of Inato across 7 years, from founding to its latest funding, stage changes and deals.

  1. Founded Inato is founded.
  2. Funding First funding round of $1.5M.
  3. Funding Latest funding round, Series A, of $20.0M.

Web traffic of Inato

The website of Inato (inato.com) receives about 3.2K visits a month and ranks #3,887,993 among all websites worldwide, #4,939 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    3.2K

    ▼ 46.5% vs previous month

  • Unique visitors
    1.4K

    per month

  • Global rank
    #3,887,993

    among all websites

  • Category rank
    #4,939

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Inato. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
avitaclinicalresearch1-my.sharepoint.com
avitaclinicalresearch1-my.sharepoint.com
100%
–
clinicaltrials.gov
66%
3.3M#13,034View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Inato

Premium access

Complete news archive for Inato

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Inato

Inato was founded in 2016 and raised its 1st funding round 1 year after it was founded.

Inato is headquartered in Paris, France.

Inato is a funded company, having raised a total of $35.52M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.52M, raised on Nov 2017.

Inato was founded in 2016 in Paris, France, as an AI-based platform focused on patient recruitment for clinical trials. Data-driven site selection is enabled through processes that identify potential sites, collect site information, assess recruitment capabilities, and model optimization strategies. End-to-end services are provided to support personalized recruitment in the health technology sector.

Inato offers AI Patient Pre-Screening and AI Site Selection.

Inato has 9 investors. Key investors include Cathay Innovation, Obvious Ventures, La Maison Partners, Top Harvest Capital, and Fly Ventures.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available